OBSERVATIONAL TRAILS IN LIPIDOLOGY

OBSERVATIONAL TRAILS IN LIPIDOLOGY

Show other versions (1)

<p>Approaches to the evaluation of drug efficacy and safety are discussed. The specifics of clinical and observational trails are presented. The trail data on statins efficacy and safety are held up as a model.</p>

Bibliographic Details
Main Author:	S. A. Shalnova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	рандомизированные клинические исследования наблюдательные исследования статины розувастатин
Online Access:	http://www.rpcardio.ru/jour/article/view/638

Similar Items

LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015-12-01)

ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT?
by: L. N. Malay
Published: (2016-01-01)

Assessment of adherence to medication and visits in healthcare facilities for cardiovascular patients who participated in international randomized controlled trials
by: N. O. Vasyukova, et al.
Published: (2019-12-01)

Observational studies and registers. Their quality and role in modern evidence-based medicine
by: S. Yu. Martsevich, et al.
Published: (2021-03-01)

News of the European Society of Cardiology Congress (London, 28 August - 2 September 2015): old drugs may be better than the new ones
by: S. Yu. Martsevich, et al.
Published: (2015-11-01)

Arterial hypertension in elderly patients aged over 60 years
by: P. Kh. Dzhanashiya, et al.
Published: (2009-04-01)

Есть ли будущее у рандомизированных исследований в сердечно-сосудистой хирургии в РФ?
Published: (2018-06-01)

Russian cardiological clinical trials
by: S. N. Tolpygina, et al.
Published: (2010-12-01)

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
by: Jan P. Vandenbroucke, et al.
Published: (2022-07-01)

Could evidence-based medicine results be reproduced in real-world clinical practice?
by: S. Yu. Martsevich, et al.
Published: (2008-06-01)

Pragmatic clinical trials
by: O. R. Shevchenko, et al.
Published: (2020-09-01)

CLINICAL DEVELOPMENT STRATEGY FOR COPIES OF PREVIOUSLY REGISTERED DRUGS. PART 3. PROTOCOL OF CLINICAL TRIAL OF BIOEQUIVALENCE
by: K. A. Yatsenko, et al.
Published: (2019-01-01)

Preliminary Results of Adding Meglumine Sodium Succinate to the Treatment of Patients with Moderate to Severe Acute Pancreatitis
by: A. L. Kovalenko, et al.
Published: (2021-02-01)

Review of real-world data study
by: T. A. Goldina, et al.
Published: (2021-04-01)

Management of postmenopausal women: what the clinician can rely on?
by: S. V. Yureneva, et al.
Published: (2014-12-01)

Investigation of rubella vaccine maked MICROGEN Federal State Company: study I trial
by: A. N. Mironov, et al.
Published: (2011-02-01)

Подготовка специалистов в области проведения клинических исследований лекарственных средств в системе послевузовского профессионального образования врачей
Published: (2018-06-01)

Перспективы популяционного скрининга рака предстательной железы
by: Антон Барчук
Published: (2017-12-01)

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
by: Jérémie F. Cohen, et al.
Published: (2022-07-01)

Treatment of macular diseases: an overview of key randomized clinical trials
by: E. V. Bobykin, et al.
Published: (2022-01-01)

Population-nosological research biobank of the National Medical Research Center for Therapy and Preventive Medicine: analysis of biosamples, principles of collecting and storing information
by: O. V. Kopylova, et al.
Published: (2022-01-01)

Мониторинг клинического исследования
Published: (2018-06-01)

Аудит клинического исследования
Published: (2018-06-01)

MOTIVATION AND PARTICIPATION EXPERIENCE OF HEALTHY VOLUNTEERS IN THE CLINICAL TRIALS OF BIOEQUIVALENCE IN RUSSIA
by: I. V. Mareev, et al.
Published: (2019-01-01)

STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE
by: L. N. Malay
Published: (2015-09-01)

Modern views on clinical and economical effectiveness of rosuvastatin
by: S. K. Zyryanov, et al.
Published: (2008-02-01)

APPLICABILITY OF DRY MILK DRINKS IN THE NUTRITION OF CHILDREN AFTER ONE YEAR
by: N. G. Zvonkova, et al.
Published: (2014-07-01)

Особенности терапевтического действия препарата ноотропного ряда Луцетам
Published: (2018-06-01)

Информированное согласие в клинических испытаниях лекарственных средств
Published: (2018-06-01)

Объективизация достоверности при планировании и оценке результатов клинических исследований
Published: (2018-06-01)

Комбинированные конечные точки в клинических исследованиях: обзор публикаций
Published: (2018-06-01)

Пути минимизации систематических отклонений от протокола клинического исследования
Published: (2018-06-01)

Risks of clinical trial protocol amendments according to duration of the trial
by: A. A. Eleskina, et al.
Published: (2023-07-01)

REASONS FOR Β-ADRENOBLOCKER USE IN ARTERIAL HYPERTENSION: ONE MORE TIME ABOUT PRO AND CONTRA
by: V. I. Makolkin
Published: (2016-01-01)

NEWS FROM THE ANNUAL CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY (BARCELONA 2014): REALIZED AND UNREALIZED EXPECTATIONS
by: S. Y. Martsevich, et al.
Published: (2015-09-01)

Stents in coronary heart disease patients: review of the studies available
by: L. A. Bokeriya, et al.
Published: (2009-02-01)

STATINS AND MYOPATHY: MOLECULAR MECHANISMS
by: O. M. Drapkina, et al.
Published: (2015-12-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Клинические исследования в педиатрической практике
Published: (2018-06-01)

Стратегия кризис-менеджмента клинических исследований
Published: (2018-06-01)